Literature DB >> 8929547

C-C chemokine-induced eosinophil chemotaxis during allergic airway inflammation.

N W Lukacs1, T J Standiford, S W Chensue, R G Kunkel, R M Strieter, S L Kunkel.   

Abstract

The production of eosinophil-specific chemotactic factors during allergic airway responses may be a pivotal event resulting in eosinophil accumulation, activation, and airway damage. Recent studies have identified specific chemokines that may play crucial roles in recruitment of eosinophils to the site of allergic reactions. In this study we have utilized an established model of schistosome egg antigen (SEA) -mediated allergic responses to examine the role of specific C-C chemokines [macrophage inflammatory protein-1alpha (MIP-1alpha), RANTES, and monocyte chemoattractant protein-1 (MCP-1)] in eosinophil recruitment. We have previously identified a role for MIP-1alpha in eosinophil accumulation in the lung and airway during allergic airway inflammation. We extend those studies using in vitro eosinophil chemotaxis to establish that both MIP-1alpha and RANTES are potent eosinophil chemotactic factors in lungs during allergic airway responses. Morphometric analysis demonstrated a peribronchial accumulation of eosinophils within the lungs beginning at 8 h, peaking at 24 h, and plateauing at 48-96 h after allergen (SEA) challenge. Utilizing whole-lung homogenates from allergen-challenged mice, in vitro eosinophil chemotactic assays demonstrated significant increases in eosinophil chemotactic activity with 8-h lung homogenates and peak activity with samples from 24-h lung homogenates. These data correlated with the morphometric analysis of peribronchial eosinophil accumulation in situ. When lung homogenates from allergen-challenged mice were preincubated in vitro with antibodies specific for MIP-1alpha, RANTES, or MCP-1, a significant reduction in eosinophil chemotaxis was observed with only MIP-1alpha and RANTES neutralization. Altogether, these studies indicate that RANTES and MIP-1alpha are major eosinophil chemotactic factors produced during allergic airway responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929547     DOI: 10.1002/jlb.60.5.573

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  24 in total

Review 1.  Chemokines and asthma: redundancy of function or a coordinated effort?

Authors:  N W Lukacs; S H Oliveira; C M Hogaboam
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  The CC chemokine MIP-1alpha induces a selective monocyte infiltration following intradermal injection into nonhuman primates.

Authors:  P J Didier; T J Paradis; R P Gladue
Journal:  Inflammation       Date:  1999-02       Impact factor: 4.092

3.  Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation.

Authors:  Alison E John; Molly S Thomas; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

4.  Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Authors:  Lia M Haynes; Les P Jones; Albert Barskey; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  In utero supplementation with methyl donors enhances allergic airway disease in mice.

Authors:  John W Hollingsworth; Shuichiro Maruoka; Kathy Boon; Stavros Garantziotis; Zhuowei Li; John Tomfohr; Nathaniel Bailey; Erin N Potts; Gregory Whitehead; David M Brass; David A Schwartz
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

6.  Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.

Authors:  Vladislav A Dolgachev; Matthew R Ullenbruch; Nicholas W Lukacs; Sem H Phan
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

7.  Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade.

Authors:  Dai Miyazaki; Takao Nakamura; Masaharu Ohbayashi; Chuan Hui Kuo; Naoki Komatsu; Keiko Yakura; Takeshi Tominaga; Yoshitsugu Inoue; Hidemitsu Higashi; Meguru Murata; Shuzo Takeda; Atsuki Fukushima; Fu-Tong Liu; Marc E Rothenberg; Santa Jeremy Ono
Journal:  Int Immunol       Date:  2009-01-15       Impact factor: 4.823

8.  Regulation of TLR2 expression and function in human airway epithelial cells.

Authors:  Tamene Melkamu; Diane Squillace; Hirohito Kita; Scott M O'Grady
Journal:  J Membr Biol       Date:  2009-06-10       Impact factor: 1.843

9.  Eosinophil activation of fibroblasts from chronic allergen-induced disease utilizes stem cell factor for phenotypic changes.

Authors:  Vladislav Dolgachev; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

10.  Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4+ CD25+ Foxp3+ T cells independent of interleukin-10.

Authors:  Lucila G G Pacífico; Fábio A V Marinho; Cristina T Fonseca; Michele M Barsante; Vanessa Pinho; Policarpo A Sales-Junior; Luciana S Cardoso; Maria Ilma Araújo; Edgar M Carvalho; Geovanni D Cassali; Mauro M Teixeira; Sergio C Oliveira
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.